NYSEARCA:RYH - NYSE Arca - US46137V3327 - ETF - Currency: USD
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as patents for some of the industry's blockbuster drugs are on the expiration cliff.
Like many U.S.-listed stocks, U.S.-listed ETFs have not gotten off to a great start in 2022. Here are 10 funds to buy on the dip.
Vaccine news this week has failed to give the health-care sector a lift. Mark Newton of Newton Advisors shares three charts that put the move into context.
Closed-end funds were doubly decimated in 2020’s selloff. For these funds, a positive gain so far this year is no meager accomplishment.
Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.
The health care sector has taken its lumps this year. For much of 2019, the second-largest sector weight in the S&P 500 has been a laggard and, as just one example of that...
With markets at sky-high levels, JC O'Hara says health care could offer value. John Petrides likes Verizon.
Utility stocks have not only soared during the past 12 months, they have also measured up well over the long haul.
Even a broad index fund may not be as diversified as you think. The reshuffled S&P sectors, for example, mean Apple is an even bigger part of the tech segment.
The most popular healthcare ETF, XLV follows the Health Care Select Sector Index. This fund manages nearly $16.9 billion in its asset base and trades in heavy volume of around 7.9 million shares.